Compare SEER & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SEER | HGLB |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.0M | 122.2M |
| IPO Year | 2020 | 2015 |
| Metric | SEER | HGLB |
|---|---|---|
| Price | $1.56 | $4.95 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 142.8K | ★ 176.9K |
| Earning Date | 11-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,578,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.99 | N/A |
| 52 Week Low | $1.55 | $4.75 |
| 52 Week High | $2.38 | $10.11 |
| Indicator | SEER | HGLB |
|---|---|---|
| Relative Strength Index (RSI) | 27.98 | 13.55 |
| Support Level | N/A | N/A |
| Resistance Level | $1.85 | $7.67 |
| Average True Range (ATR) | 0.12 | 0.27 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 5.45 | 11.32 |
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.